Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome
Mihály Józsi(Eötvös Loránd University), Wei-shih Liu(University of Duisburg-Essen), Martin Oppermann(Technische Universität Dresden), Endre Sulyok(University of Pecs), Peter F. Zipfel(Systems Analytics (United States)), Heiko Richter(Max Planck Institute for Innovation and Competition), Peter F. Hoyer(Essen University Hospital), Christoph J. Mache(Medical University of Graz)
Cited by 78
Related Papers
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
|Blood|2007|356
Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
|PLoS Genetics|2007|325
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)
|Kidney International|2006|203